One interesting target molecule for the treatment of defined tumor entities is the secreted growth factor pleiotrophin (PTN), also known as HB-GAM (heparin biding growth associated molecule) or HARP (heparin affinity regulatory peptide). This evidence concerns the gene PTN and neoplasm.